Janney Montgomery Scott
AXDX icon

Janney Montgomery Scott’s Accelerate Diagnostics AXDX Stock Holding History

Janney Montgomery Scott’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,616
Closed -$335K – 1743
2016
Q4 		$335K Buy
+1,616
New +$384K 0.01% 1264

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ArrowMark Colorado Holdings
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
JP Morgan Private Wealth Advisors
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return

Janney Montgomery Scott's AXDX Position: Q1 2017 in Review

Janney Montgomery Scott sold out of Accelerate Diagnostics (AXDX) in Q1 2017, closing a stake of 1,616 shares — an estimated $335K sold.

Janney Montgomery Scott first reported a position in AXDX in Q4 2016 and held it in 1 quarter. The position peaked at $335K in Q4 2016. 98 funds tracked by Wall St. Rank hold AXDX as of Q1 2017.

  • Janney Montgomery Scott reported no remaining Accelerate Diagnostics position as of Q1 2017 after selling out during the quarter.
  • Janney Montgomery Scott sold 1,616 Accelerate Diagnostics shares in Q1 2017, an estimated $335K.
  • Janney Montgomery Scott first reported a position in Accelerate Diagnostics in Q4 2016 and held it in 1 quarter.
  • Janney Montgomery Scott's Accelerate Diagnostics position peaked at $335K in Q4 2016.
  • 98 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2017.

Based on Janney Montgomery Scott's 13F filing for Q1 2017, filed 26 Apr 2017.